Evidence map›Paper›PMID 33580285›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2021

Cross-sectional study of sex differences in psychosocial quality of life of long-term melanoma survivors.

Rachel I Vogel, Broderick Yoerg, Patricia I Jewett, Nathan Rubin, Megan Olson, Ashley E Stenzel, Rehana L Ahmed, DeAnn Lazovich

Open access · greenAbstract read
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Development and validation of the Essen Melanoma Quality of Life Inventory (EMQoLI).Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Rachel I VogelDepartment of Obstetrics, Gynecology and Women's Health, Division of Gynecologic Oncology, University of Minnesota, 420 Delaware Street SE, MMC 395, Minneapolis, MN, 55455, USA. isak0023@umn.edu.ORCID http://orcid.org/0000-0003-0149-8464
Broderick YoergCollege of Continuing Education and Professional Studies, University of Minnesota, Minneapolis, MN, 55455, USA.
Patricia I JewettDepartment of Obstetrics, Gynecology and Women's Health, Division of Gynecologic Oncology, University of Minnesota, 420 Delaware Street SE, MMC 395, Minneapolis, MN, 55455, USA.
Nathan RubinMasonic Cancer Center, University of Minnesota, Minneapolis, MN, 55455, USA.
Megan OlsonDepartment of Obstetrics, Gynecology and Women's Health, Division of Gynecologic Oncology, University of Minnesota, 420 Delaware Street SE, MMC 395, Minneapolis, MN, 55455, USA.
Ashley E StenzelDepartment of Obstetrics, Gynecology and Women's Health, Division of Gynecologic Oncology, University of Minnesota, 420 Delaware Street SE, MMC 395, Minneapolis, MN, 55455, USA.
Rehana L AhmedMasonic Cancer Center, University of Minnesota, Minneapolis, MN, 55455, USA.
DeAnn LazovichMasonic Cancer Center, University of Minnesota, Minneapolis, MN, 55455, USA.
University of Minnesota · USUniversity of Minnesota Medical Center · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Douglas Yee · 1998 to 2026
$100.4M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR002494 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, WEISDORF, DANIEL J · 2018 to 2022
$34.9M
Cancer Related Health Disparities Training ProgramT32CA163184 · NCI · UNIVERSITY OF MINNESOTA · PI MICHELE L ALLEN, Irina Stepanov · 2016 to 2026
$3.4M
NCATS NIH HHS UL1 TR002494NCATS NIH HHS UL1TR002494NCI NIH HHS P30 CA077598NCI NIH HHS P30 CA77598NCI NIH HHS T32 CA163184NCI NIH HHS T32CA163184
6 · The paper itself

Abstract

purposeA cancer diagnosis and subsequent treatment can have a significant impact on an individual's quality of life. Differences in quality of life by sex among long-term melanoma survivors remain unclear. The objective of this study was to describe sex differences in cancer-specific psychosocial quality of life of long-term melanoma survivors.

methodsMelanoma survivors 7-10 years post-diagnosis from a previously conducted population-based case-control study were recruited for a cross-sectional survey. Validated measures of psychosocial quality of life related to melanoma diagnosis were assessed. Outcomes were compared by sex using linear regression models adjusting for age, education, income, and marital status.

resultsThe survey response rate was 62% (433 females, 291 males; 86% stage I disease). Females were more likely to report changes in their appearance (p = 0.006) and being more fearful of recurrence (p = 0.001) or a second melanoma (p = 0.001) than males but were also more likely to report that melanoma had a positive impact on their lives (p < 0.0001). Males were more likely to agree with statements that emphasized that life's duration is limited (p < 0.0001).

conclusionLong-term melanoma survivors reported generally favorable measures of psychosocial quality of life related to their diagnosis. Females and males reported unique quality of life concerns and may require varied methods of support following a melanoma diagnosis.

Indexed as

Cancer SurvivorsMelanomaCase-Control StudiesCross-Sectional StudiesFemaleHumansMaleNeoplasm Recurrence, LocalQuality of LifeSex CharacteristicsCancer survivorshipMelanomaQuality of lifeSex differences

Identifiers

PMID33580285
PMCPMC8457518
OpenAlexW3127653384

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.